the latest posts from Adolfo Meza
Adolfo Meza is a serial entrepreneur, trendsetter and expert in marketing, product and business development who holds an MBA from SDSU, a EE from Universidad Iberoamericana and is currently the principal at LYKOS Consulting.
To dream is to go within, to day-dream is to go within consciously. It involves vividly connecting to our passions and allowing our emotions to paint a picture of the life we want.
To filter through the noise and align one's abilities, resources and time to the fulfillment of a particular idea. To focus your energy on accomplishing your dreams is to open your mind to learning, co-creating with peers and sharing your creation with others.
To accomplish a goal mindfully and enjoy the fulfillment of success, one must meet a goal that is personal in nature and is aligned to one's passions. Flowing with the necessary changes and adapting to new inputs as they come will keep you actively pursuing the continuous improvement of your dream that has now become a reality thanks to your focused and passionate efforts.
The difference between Dreaming and Doing is Focus.Adolfo Meza
The human body produces certain cannabinoids on its own. It has two receptors for cannabinoids, called CB1 receptors and CB2 receptors.
CB1 receptors are found all around the body, but many of them are in the brain.
The CB1 receptors in the brain deal with coordination and movement, pain, emotions and mood, thinking, appetite, and memories, among others. THC attaches to these receptors.
CB2 receptors are more common in the immune system. They affect inflammation and pain.
It used to be thought that CBD acts on these CB2 receptors, but it appears now that CBD does not act on either receptor directly. Instead, it seems to influence the body to use more of its own cannabinoids.
People interested in managing their anxiety with CBD oil should look exclusively at research on cannabidiol, not generalized studies of medical marijuana. Although there are fewer studies on cannabidiol specifically, the preliminary research is promising.
A small 2010 study (http://journals.sagepub.com/doi/abs/10.1177/0269881110379283) found that cannabidiol could reduce symptoms of social anxiety in people with social anxiety disorder (SAD). Brain scans of participants revealed changes in blood flow to the regions of the brain linked to feelings of anxiety.
In this study, cannabidiol not only made participants feel better but also changed the way their brains responded to anxiety.
A 2011 study (https://www.nature.com/articles/npp20116?foxtrotcallback=true) also found that cannabidiol could reduce social anxiety. For that study, researchers looked specifically at cannabidiol to treat anxiety associated with public speaking.
Research published in 2014 (https://www.ncbi.nlm.nih.gov/m/pubmed/24923339/) found that CBD oil had anti-anxiety and antidepressant effects in an animal model.
Cannabidiol from Hemp may still contain trace amounts of THC (up to 0.3%) So, although legal in 50 states and not derived directly from the cannabis plant someone using cannabidiol might still test positive for THC on a drug test, even though they will not experience any alterations of mental state after using the oil. Consult your local laws before purchasing.
Some people feel that CBD offers a more natural way to lower pain. A study (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/) published in the Journal of Experimental Medicine found that CBD significantly reduced chronic inflammation and pain in some mice and rats.
The researchers suggest that the non-psychoactive compounds in marijuana, such as CBD, could be a new treatment for chronic pain.
- smoking cessation and drug withdrawal
- treating seizures and epilepsy (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/)
- anxiety treatment (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/)
- reducing some of the effects of Alzheimer's, as shown by initial research
- antipsychotic effects on people with schizophrenia
- future applications in combating acne
- (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/), type 1 diabetes (https://www.ncbi.nlm.nih.gov/m/pubmed/27767974/), and cancer (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579246/)
Although more research is required to confirm some uses of CBD oil, it is shaping up as a promising and versatile treatment.
Studies suggest that CDP-choline supplements increase dopamine receptor densities. Nootropics are studied for their positive effects leading to increased concentration, enhanced memory, improved brain health, anti-aging benefits and improved mood.